Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	1.07B +416.6%
Revenue (ttm)	1.28B +1,084.2%
Net Income	18.06M +802.3%
EPS	1.20 +458.7%
Shares Out	19.94M
PE Ratio	44.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,231
Average Volume	3,189
Open	51.30
Previous Close	54.86
Day's Range	50.60 - 54.90
52-Week Range	27.94 - 70.16
Beta	0.37
RSI	44.62
Earnings Date	May 26, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In fiscal year 2025, Novelix Pharmaceuticals's revenue was 307.33 million, an increase of 578.26% compared to the previous year's 45.31 million. Earnings were 845,200, an increase of 711.76%.